These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 31864341

  • 1. Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer.
    Sastre D, Baiochi J, de Souza Lima IM, Canto de Souza F, Corveloni AC, Thomé CH, Faça VM, Schiavinato JLDS, Covas DT, Panepucci RA.
    BMC Cancer; 2019 Dec 21; 19(1):1239. PubMed ID: 31864341
    [Abstract] [Full Text] [Related]

  • 2. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z, Wei J, You W, Wang R, Shang J, Xiong Y, Yang H, Yang X, Fu Z.
    J Transl Med; 2017 Dec 19; 15(1):257. PubMed ID: 29258530
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells.
    Yadav P, Sharma P, Chetlangia N, Mayalagu P, Karunagaran D.
    Chem Biol Interact; 2022 Dec 01; 368():110224. PubMed ID: 36272469
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E, Rasmi Y, Baradaran B.
    J Cell Physiol; 2021 Oct 01; 236(10):7071-7087. PubMed ID: 33821473
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
    Xu X, Chen R, Li Z, Huang N, Wu X, Li S, Li Y, Wu S.
    BMC Cancer; 2015 Dec 29; 15():1023. PubMed ID: 26714817
    [Abstract] [Full Text] [Related]

  • 9. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
    Chang S, Sun G, Zhang D, Li Q, Qian H.
    Cell Death Dis; 2020 Jul 27; 11(7):592. PubMed ID: 32719361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
    Wu YZ, Lin HY, Zhang Y, Chen WF.
    J Gene Med; 2020 Jul 27; 22(7):e3178. PubMed ID: 32092782
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR.
    Qu X, Yang L, Shi Q, Wang X, Wang D, Wu G.
    Pathol Res Pract; 2018 Dec 27; 214(12):1974-1979. PubMed ID: 30262429
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K, Zhou X, Yu J, Li Q, Wang H, Li M, Shao Z, Zhang F, Luo Y, Shen Z, Chen F, Shi F, Cui C, Zhao D, Lin Z, Zheng W, Zou Z, Huang Z, Zhao L.
    Cancer Lett; 2016 Jun 28; 376(1):178-87. PubMed ID: 27037061
    [Abstract] [Full Text] [Related]

  • 20. Circ-ACAP2 facilitates the progression of colorectal cancer through mediating miR-143-3p/FZD4 axis.
    Zhang G, Liu Z, Zhong J, Lin L.
    Eur J Clin Invest; 2021 Dec 28; 51(12):e13607. PubMed ID: 34085707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.